Maimon Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Maimon Wealth Management's LLY Position: Q2 2026 in Review
Maimon Wealth Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,327 shares — an estimated $1.18M sold.
Maimon Wealth Management first reported a position in LLY in Q4 2025 and held it in 2 quarters. The position peaked at $1.43M in Q4 2025. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Maimon Wealth Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- Maimon Wealth Management sold 1,327 Eli Lilly shares in Q2 2026, an estimated $1.18M.
- Maimon Wealth Management first reported a position in Eli Lilly in Q4 2025 and held it in 2 quarters.
- Maimon Wealth Management's Eli Lilly position peaked at $1.43M in Q4 2025.
- 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Maimon Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.